In this research, HLT-101 induced apoptosis in prostate cancer cells by downregulating the expression of BCL-2, an apoptosis inhibitor, and up-regulating BAX, a pro-apoptotic factor. This evidence concerns the gene BCL2 and prostate carcinoma.